Trials / Completed
CompletedNCT06927700
Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,257 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food \& Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multiple disease) versus ads with no reduced-risk claims, and examine effects on message and product perceptions, and interest in using the smokeless tobacco products. This study will also examine how smokers' reactions/interest may vary based on the product brand, and asses prior awareness/exposure to the authorized claims.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Modified Risk Claim Type - None | Participants will view smokeless tobacco ads with no modified risk claim (control) |
| BEHAVIORAL | Product Brand - General Snus | Participants will views ads for the smokeless tobacco brand General Snus |
| BEHAVIORAL | Product Brand - Copenhagen | Participants will views ads for the smokeless tobacco brand Copenhagen |
| BEHAVIORAL | Modified Risk Claim Type - Multiple Diseases | Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases |
| BEHAVIORAL | Modified Risk Claim Type - Lung Cancer | Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only |
Timeline
- Start date
- 2025-04-24
- Primary completion
- 2025-05-04
- Completion
- 2025-05-04
- First posted
- 2025-04-15
- Last updated
- 2026-03-04
- Results posted
- 2026-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06927700. Inclusion in this directory is not an endorsement.